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Abstract
Bacterial cholesterol oxidase is commonly used as an experimental tool to reduce cellular cholesterol content. That the
treatment also generates the poorly degradable metabolite 4-cholesten-3-one (cholestenone) has received less attention.
Here, we investigated the membrane partitioning of cholestenone using simulations and cell biological experiments and
assessed the functional effects of cholestenone in human cells. Atomistic simulations predicted that cholestenone reduces
membrane order, undergoes faster flip-flop and desorbs more readily from membranes than cholesterol. In primary human
fibroblasts, cholestenone was released from membranes to physiological extracellular acceptors more avidly than
cholesterol, but without acceptors it remained in cells over a day. To address the functional effects of cholestenone, we
studied fibroblast migration during wound healing. When cells were either cholesterol oxidase treated or part of cellular
cholesterol was exchanged for cholestenone with cyclodextrin, cell migration during 22 h was markedly inhibited. Instead,
when a similar fraction of cholesterol was removed using cyclodextrin, cells replenished their cholesterol content in 3 h and
migrated similarly to control cells. Thus, cholesterol oxidation produces long-term functional effects in cells and these are in
part due to the generated membrane active cholestenone.
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Introduction
Cholesterol is a vital constituent in the plasma membrane of
higher eukaryotes, where it typically represents 25–40% of total
lipids [1,2]. Cholesterol regulates biophysical membrane proper-
ties such as fluidity, permeability, and rigidity. It interacts with
neighbouring lipids and proteins via steric interactions and via
hydrogen bonding through its 3b-hydroxyl group. The interac-
tions between cholesterol and polar phospholipids can locally
increase lipid order. This leads to the formation of dynamic
membrane domains that contribute to the regulation of key
cellular processes, such as receptor signaling, endocytosis and cell
polarity [3,4].
To assess the functional importance of cholesterol, membrane
cholesterol content is often reduced experimentally. Typically,
cholesterol is extracted using methyl-b-cyclodextrin (MBCD),
which can deplete up to 80–90% of plasma membrane cholesterol
[5]. Another commonly used method is to expose the membrane
to purified bacterial cholesterol oxidase (coase) [4,6–10]. Enzy-
matic cholesterol oxidation and cholesterol removal by MBCD are
often used interchangeably for cholesterol reduction but they act
via different mechanisms; MBCD extrudes cholesterol from the
membrane, whereas coase catalyzes the conversion of up to,20%
of cellular cholesterol to 4-cholesten-3-one (cholestenone)
[7,11,12]. Cholesterol oxidizing bacteria can further catabolize
cholestenone to use it as their nutritional hydrocarbon source.
However, in mammals, cholestenone is metabolized primarily in
the liver [13,14]. Therefore, once generated, cholestenone is likely
to persist in extrahepatic mammalian cells.
In cholestenone, the steroid 3-hydroxyl group is replaced by a keto
group, with a more limited capacity for hydrogen bonding than a
hydroxyl group. Consequently, cholestenone preferentially localizes
to liquid-disordered (Ld) domains in model membranes and causes
lipid monolayer expansion [12,15,16]. While coase treatment is
widely used to disturb cholesterol domains in cell membranes
[4,7,10,17,18], the membrane partitioning and effects of choleste-
none in the cellular context have so far received little attention.
In this study, we characterized the effects of coase treatment on
membrane order and steroid mobility in primary human dermal
fibroblasts (HDFs). The molecular interactions involved in
cholestenone membrane partitioning and desorption from the
membrane were addressed using atomistic simulations. Our data
suggest that cholestenone is highly mobile in membranes and
influences cholesterol flip-flop and efflux. Moreover, we provide
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evidence that in contrast to MBCD induced cholesterol depletion
cholesterol oxidation causes long-term functional defects in cells
due to the persistence of cholestenone.
Results and Discussion
Cholesterol oxidation reduces membrane order and
increases steroid flip-flop
To assess if coase treatment (Figure 1A) affects membrane
fluidity in HDFs, we analysed the generalized polarization (GP) of
the fluorescent probe Laurdan. Coase treatment at 37uC for 1 h
converted approximately 20% of cellular cholesterol into choles-
tenone. This treatment was compared to moderate or severe
cholesterol depletion by MBCD, extracting ,25% or ,50% of
cellular cholesterol, respectively. We found that cholesterol
oxidation and moderate MBCD-mediated cholesterol depletion
resulted in a similar degree of GP reduction, while severe
cholesterol depletion caused a larger decrease in GP (Figure 1B,
C). Thus, the range of increase in membrane fluidity was roughly
proportional to the level of cholesterol depletion (R2 = 0.95).
However, it is worth noting that MBCD treatment may also result
in the extraction of other membrane lipids [5].
In line with GP measurements, atomistic molecular dynamics
(MD) simulations in a raft-like bilayer (palmitoyl-oleyl phospha-
tidylcholine (POPC): N-palmitoyl-sphingomyelin (PSM): choles-
terol, molar ratio 2:1:1) predicted a substantial decrease in the
ordering of the palmitoyl chain of POPC when 25% of cholesterol
was replaced by cholestenone (Figure 1D). Interestingly, 25%
replacement of cholesterol by cholestenone decreased palmitoyl
chain ordering almost as much as complete replacement of
cholesterol by cholestenone, indicating that cholestenone affects
the ordering capability of the remaining cholesterol. However, all
of the simulated raft-like membranes with a total of 25 mol%
steroid were more ordered than a liquid-disordered bilayer
(Figure 1D). In addition, the replacement of cholesterol by
cholestenone had a minor effect on the lateral diffusion of PSM,
increasing it at short times (Figure S1).
Atomistic MD simulations were also used to analyse how
cholestenone affects the movement of the steroid molecules
between membrane leaflets. One of the most striking observations
was the frequent occurrence of inter-leaflet movements or flip-flop
motions of cholestenone molecules (Figure 2A, B). In contrast to
cholestenone, cholesterol exhibited a very stable vertical position
along the bilayer normal, with rare flip-flops (Figure 2B). The
increased flip-flop rate of cholestenone is in accordance with its
decreased hydrogen-bonding capacity compared with that of
cholesterol (Table 1).
To gain a more quantitative view of the steroid inter-leaflet
movements, we performed free energy calculations using umbrella
sampling [19]. The free energy profiles are shown in Figure 2C,
and the free energy values associated with these processes in
Table 2. The results obtained for cholesterol are in agreement
with previous studies [20–22]. The free energy of both steroids had
a minimum at the equilibrium position (with oxygen located at the
bilayer interface) and increased toward the bilayer center as well as
toward bulk water (Figure 2C).
The difference in the flip-flop movements of cholesterol and
cholestenone was reflected in their free-energy values. We found
that the free energy barrier for cholestenone flip-flop was about
four times lower than that of cholesterol (Figure 2C, Table 2).
Consequently, cholestenone flip-flop took place on a nanosecond
timescale, whereas cholesterol flip-flop occurred on a timescale of
microseconds to milliseconds (Table 2). Also, the flip-flop rate of
cholesterol was increased 3-fold in the presence of cholestenone,
whereas cholestenone flip-flop was consistently fast and less
dependent on other membrane lipids (Table 2). Increased flip-
flop is likely to decrease the lateral pressure and increase elasticity
of the membrane [23,24]. No pore formation was observed, unlike
in flip-flops of phospholipids [25,26].
Atomistic simulations predicted that cholestenone desorbs from
the membrane to the water phase more readily than cholesterol. In
a raft-like membrane containing a mixture of cholesterol and
cholestenone, the free energy barriers for desorption were 70.6
and 65.4 kJ/mol for cholesterol and cholestenone, respectively. In
a Ld membrane, the corresponding values were 62 and 57.8 kJ/
mol. The simulations thereby showed a consistent 7.3% reduction
in the free energy barrier for cholestenone compared with
cholesterol, suggesting that cholestenone fluxes from the mem-
brane more easily than cholesterol.
Cholestenone is transferred from HDFs to extracellular
acceptors more readily than cholesterol
To study if cholestenone is released more avidly than cholesterol
from biological membranes, we analysed the efflux of radiolabeled
cholesterol and cholestenone from HDFs. For this purpose, HDFs
were labeled with [14C]cholesterol for 42 h, and then oxidized
with coase (10 U/ml) for 1 h to produce [14C]cholestenone. This
resulted in the oxidation of 17.462.7% of [14C]cholesterol. In
control experiments, cells were either mock treated or treated with
0.5 mM MBCD to deplete ,25% of [14C]cholesterol. The efflux
of radiolabeled cholesterol and cholestenone from HDFs was
analysed after 4 h of chase in a buffer containing either
Apolipoprotein A-I (ApoA-I) or bovine serum albumin (BSA) as
lipid acceptors (Figure 3A).
We observed that [14C]cholestenone underwent efflux from
HDFs much more efficiently than [14C]cholesterol: the efflux of
[14C]cholestenone to ApoA-I was ,2.5 times higher than that of
[14C]cholesterol from control cells (Figure 3B). The difference
was even more pronounced when BSA was used as the acceptor,
with the proportion of [14C]cholestenone delivered to BSA being
roughly 5 times higher than that of [14C]cholesterol in control cells
(Figure 3C). Interestingly, the efflux of [14C]cholesterol to ApoA-
I or BSA was markedly reduced in coase-treated cells, while
MBCD pretreatment did not affect this: Approximately 5% of
[14C]cholesterol was released to ApoA-I and ,2% to BSA in
control and MBCD-treated cells; instead, when cells were
pretreated with coase, only 1% of [14C]cholesterol was transferred
to ApoA-I or BSA (Figure 3B, C).
Thus, cholestenone was more readily transferred from HDF
membranes to extracellular acceptors than cholesterol. Moreover,
introduction of cholestenone into the membrane inhibited the
release of cholesterol to extracellular acceptors. This is in apparent
contradiction to our simulation results where the presence of
cholestenone rather facilitated cholesterol desorption (Table 2).
The reason for this difference is not clear, but one possibility is that
the reduced cholesterol efflux in coase treated cells results from
oxidation of cholesterol in domains that are only slowly
replenished via protein dependent pathway(s). For instance, the
key cholesterol efflux protein ABCA1 may play a role in
transferring cholesterol to less packed domains susceptible to
oxidation. This would be in line with the finding that ABCA1
activity increases cholestenone production by coase [27,28].
Partitioning of cholestenone and BODIPY-cholestenone
in cellular membranes
We next analysed the partitioning of [14C]cholesterol and
[14C]cholestenone (generated by coase) in cellular membrane
Cholestenone Induced Membrane Alterations
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fractions using sucrose gradient centrifugation. This showed that
the distributions of [14C]cholesterol and [14C]cholestenone were
similar apart from the slight preference of [14C]cholestenone for
lower density fractions, as evidenced by its relative enrichment in
the top fraction containing lipid droplets (LDs, enriched in
[14C]cholesteryl esters) and depletion in the bottom fraction, as
compared to [14C]cholesterol (Figure 4A).
To visualize how the removal of cholesterol’s 3b-hydroxyl group
affects lipid mobility in cell membranes, we synthesized a
fluorescently labeled analogue, BODIPY-cholestenone (Bpy-cho-
Figure 1. Cholesterol oxidation decreases membrane order. A) Structures of cholesterol and cholestenone. B) HDFs were treated at 37uC with
coase (10 U/ml; 1 h), MBCD (0.5 mM; 5 min or 5 mM; 1 h) or buffer only (ctrl). Cells were labeled with Laurdan, fixed, imaged with a 2-photon
microscope and GP images were generated. C) Average GP values calculated from the Laurdan GP data represent three independent experiments;
n = 59 fields, .300 cells per condition; ***P,0.0005. The fraction of cholesterol remaining in cells after the treatments is indicated. D) The order
parameters |SCD|, from MD simulations of the palmitoyl tail of POPC molecules in various lipid bilayers. The liquid-ordered (Lo) systems were POPC/
PSM/cholesterol/cholestenone 2:1:1:0, POPC/PSM/cholesterol/cholestenone 2:1:0.75:0.25, POPC/PSM/cholesterol/cholestenone 2:1:0:1, and the liquid-
disordered (Ld) systems were with 1 chol in a POPC bilayer and 1 cholestenone in a POPC bilayer. Carbon numbering starts from carbons close to the
glycerol group.
doi:10.1371/journal.pone.0103743.g001
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lestenone) (Figure 4B). In this lipid, the hydroxyl group of the
earlier characterized sterol analogue BODIPY-cholesterol (Bpy-
cholesterol; [29]) is replaced by a keto group, and the position of
the 5,6-double bond is changed to a 4,5-double bond, as in native
cholestenone. The trafficking of Bpy-cholesterol and Bpy-choles-
tenone was compared in living HDFs upon labeling from MBCD-
Bpy-lipid complexes. Bpy-cholesterol was localized mainly in the
plasma membrane directly after labeling (Figure 4C) and from
Figure 2. Transbilayer mobility of cholestenone and cholesterol. A) Snapshots showing the spontaneous flip-flop motion of a cholestenone
molecule during MD simulation in the raft-like system POPC/PSM/cholesterol/cholestenone 2:1:0.75:0.25. POPC and PSM are shown as green and grey
lines, respectively, with head-group phosphorus atoms as spheres. Cholesterol (chol) and cholestenone (cnone) are shown as magenta and blue ball-
and-stick representation, respectively. The particular cholestenone undergoing flip-flop is highlighted as red van der Waals spheres and its 3-keto
oxygen atom is shown in yellow. B) Time scale and frequency of flip-flops by cholesterol and cholestenone. Time evolution of the Z-coordinate of the
head group oxygen atom of cholesterol (i) and cholestenone (ii) along the bilayer normal in the system POPC/PSM/chol/cholestenone 2:1:0.8:0.2. The
Y-axis zero indicates the center of the bilayer. Different colors show different cholesterol or cholestenone molecules. The figures highlight how
different the flip-flop rates of cholesterol and cholestenone are: while cholesterol undergoes only a single quick flip-flop event, cholestenone
undergoes a large number of flip-flops during the same period. Yet the concentration of cholesterol was four times higher than that of cholestenone.
C) The potential of mean forces (kJ/mol) of cholesterol and cholestenone in a variety of lipid bilayer models (shown by dark lines), either in the liquid-
disordered (Ld) or liquid-ordered (Lo) phase. The transparent area following each PMF curve represents the corresponding statistical errors.
doi:10.1371/journal.pone.0103743.g002
Table 1. Average number of hydrogen bondsa (H-bonds) and charge pairsb formed by steroids with the surrounding lipids and
water.
System H-bonds with lipids H-bonds with water Charge pairs
chol cnone chol cnone chol cnone
IMD (POPC/PSM/chol/cnone 2:1:1:0) 0.37 (0.17/0.20)* - 1.66 - 0.61 -
IIMD (POPC/PSM/chol/cnone 2:1:0.8:0.2) 0.35 (0.18/017)* 0.04 1.67 0.53 0.60 0.46
*(per POPC, or per PSM).
aThe presence of H-bonds was evaluated based on distance and angle criteria: the donor- acceptor distance had to be less than or equal to 0.325 nm, and the angle
between the vector linking a donor and an acceptor, and the vector describing the chemical bond between hydrogen and a donor had to be less than or equal to 35u.
bThe existence of charge pairs was determined using the distance cut-off of 0.4 nm.
Errors are less than 0.01.
doi:10.1371/journal.pone.0103743.t001
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there, transported to intracellular compartments as described
[29,30], becoming concentrated in the perinuclear area at 2 h post
labeling (Figure 4C). In contrast, the vast majority of Bpy-
cholestenone was observed in intracellular compartments imme-
diately after labeling and remained in these structures (Fig-
ure 4C). This compartment was identified as LDs by co-labeling
with BODIPY558/568-C12 (Figure 4C). Bpy-cholesterol also
colocalized with LDs to some extent, but less prominently than
Bpy-cholestenone. These data indicate that the 3b-hydroxyl group
is critical for the intracellular trafficking of the Bpy-sterol. The
prominent LD localization of Bpy-cholestenone compared to the
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Figure 3. Efflux of cholestenone and cholesterol from HDFs to
extracellular acceptors. A) HDFs prelabeled with [14C]cholesterol
were treated with coase (10 U/ml; 1 h), MBCD (0.5 mM; 5 min), or mock
treated (ctrl). Efflux of radiolabeled lipids was analyzed after a 4 h chase
in serum-free buffer containing B) ApoA-I (10 mg/ml); n = 4 or C) BSA
(0.2%); n = 4–6. *P,0.05; **P,0.005; ***P,0.0005.
doi:10.1371/journal.pone.0103743.g003
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modest LD affinity of [14C]cholestenone suggests that the
hydrophobic Bpy-moiety largely drives the LD localization of
the fluorescent derivative lacking the 3b-hydroxyl group.
We also studied the removal of the Bpy-lipids from HDFs to
extracellular acceptors. At 4 h of incubation in serum-containing
medium, ,50% of Bpy-cholesterol fluorescence was retained in
the cells, whereas only ,25% of Bpy-cholestenone was retained
(Figure 4D). This shows that Bpy-cholestenone was more
efficiently effluxed from cells than Bpy-cholesterol, analogously
to the radiolabeled sterols.
Cholestenone generated upon cholesterol oxidation
restrains cell migration
To assess how persistent the cholesterol manipulations in coase-
vs. MBCD-treated HDFs were, we analysed the cellular choles-
terol and cholestenone content after the treatments. This showed
that cells treated with MBCD recovered their cholesterol content
within 3 h (Figure 5A). In contrast, in coase treated cells
cholestenone and the accompanying cholesterol reduction persist-
ed at 3 h as well as at 22 h post oxidation (Figure 5A).
The long-lasting effects of coase treatment make it a potential
tool for analysing its functional consequences in the time scale of
hours to days. We have recently reported that cholesterol is
transported to the plasma membrane to support cell migration
[31]. We therefore compared how coase and mild MBCD
treatment causing ,25% cholesterol depletion affected HDF
migration in a wound-healing assay. We found that the migration
of coase treated cells was reduced by ,65% in comparison to
MBCD or mock treated cells (Figure 5B, C). To rule out the
possibility that residual cell associated cholesterol oxidase or
Figure 4. Intracellular trafficking of cholesterol and cholestenone. A) RAW 264.7 macrophages prelabeled with [14C]cholesterol for 18 h were
treated with 10 U/ml coase for 2 h. The post-nuclear supernatant was subjected to sucrose gradient fractionation. A total of 7 fractions was collected
and analysed for radiolabeled [14C]cholesterol, -cholestenone, and -cholesteryl ester content. Inset: Percentage of [14C]cholesterol and -cholestenone
in the lowest density fraction 1; n = 4. *P,0.05. B) Structures of Bpy-cholesterol (Bpy-chol) and Bpy-cholestenone (Bpy-cnone). C) HDFs were pulse
labeled with the indicated Bpy-lipids for 8 min, and the cells were imaged by confocal microscopy during 2 h of chase. To visualize LDs, cells were
pulse labeled for 1 h with Bpy568-C12 (5 mM) and Bpy-lipid (1 mM), and imaged after a 1 h chase. Scale bars 10 mm. D) HDFs were pulse labeled with
Bpy-lipids and analysed for Bpy fluorescence intensity immediately after the pulse and after 4 h of chase in DMEM, 10% FBS; n = 8; ***P,0.0005.
doi:10.1371/journal.pone.0103743.g004
Cholestenone Induced Membrane Alterations
PLOS ONE | www.plosone.org 6 August 2014 | Volume 9 | Issue 8 | e103743
Figure 5. Coase treatment or cholestenone impairs fibroblast migration in a wound-healing assay. A) Confluent HDFs were treated with
coase (10 U/ml; 1 h), MBCD (0.5 mM; 5 min), or mock treated (ctrl) and collected for lipid extraction at the indicated time points. Cholesterol and
cholestenone amounts were determined; n = 8–16. B) HDFs were treated as in A, and wounded with a pipette tip. Cells were fixed at the indicated
time points, stained with Alexa568-phalloidin and imaged. Scale bars 20 mm. C) Cell migration area was quantified at 22 h post treatments; n = 11–15
fields. D) HDFs were incubated with MBCD-cholestenone (MB-CN) complex, collected for lipid analysis and cholesterol and cholestenone amounts
Cholestenone Induced Membrane Alterations
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putative unspecific oxidation products cause the defective cell
migration we exchanged ,20–30% of cellular cholesterol to
cholestenone from MBCD-cholestenone complex (Figure 5D).
The cholesterol/cholestenone content and migration of cells were
then assessed at 22 h. This showed that cholestenone remained in
cells (Figure 5D) and that cell migration was reduced by up to
90% (Figure 5E). This strengthens the argument that cell
migration is inhibited by cholestenone rather than by some other
coase effect.
Defective lamellipodial formation in cholestenone
containing cells
We noted that the coase-treated cells extended long filopodia-
like protrusions toward the wounded area (Figure 6A). To
elucidate some of the early changes accompanying the non-
migratory phenotype of coase-treated cells, we analysed actin in
HDFs at 3 h post wounding. Phalloidin staining revealed that in
coase treated cells the actin rich protrusions at the leading edge
were very narrow and spindle shaped, whereas control and
MBCD-treated cells exhibited prominent well spread lamellae
(Figure 6C). At this time point, the average width of the
lamellipodium in coase-treated cells was reduced by over 50%
(Figure 6B). Lamellipodium spreading depends on the actin
branch point complex Arp2/3 [32]. We found that the Arp2/3
complex component ARPC2 was efficiently recruited to the
lamellipodia of control and MBCD-treated cells at 3 h post
treatment (Figure 6C). In contrast, the coase-treated cells
displayed a prominent cytosolic ARPC2 staining, and reduced
immunostaining at the leading edge (Figure 6C). These results
suggest that actin dynamics is aberrantly regulated in the presence
of cholestenone. This agrees with earlier reports showing that
coase treatment affects the diffusion of membrane lipids and
proteins in an actin dependent manner [4,7].
An interesting question is how precisely cholestenone perturbs
actin dynamics. As there is no evidence of direct steroid-actin
interaction, it seems likely that cholestenone acts via other
membrane lipids, such as phosphoinositides (PIPs). PI(4,5)P2 and
PI(3,4,5)P3 regulate lamellipodia formation through binding to
actin interactors, such as WAVE/WASP complex proteins that
also regulate the activity of the Arp2/3 complex [33]. Interest-
ingly, PI(3,4,5)P3 production is specifically needed for lamellipo-
dial spreading during fibroblast migration [34], suggesting that
coase treatment might interfere with PI(3,4,5)P3 generation. In the
future it will be interesting to address the effects of cholestenone on
PIPs and their modifying enzymes, to further elucidate how
cholestenone perturbs membrane lipids and proteins.
In summary, this study shows that bacterial cholesterol oxidase
treatment results in pronounced changes in cell membrane
organization. Cholestenone decreases membrane order, undergoes
rapid transbilayer movements, desorbs from the membrane more
readily than cholesterol and influences cholesterol flip-flop and
efflux. In addition, we demonstrate that cholesterol oxidase
treatment results in long-term perturbation in cell motility, a
process that is highly dependent on membrane lipid composition.
This defect appears to be due to the generated cholestenone that
persists in cell membranes, affecting e.g. actin regulatory proteins
involved in the formation of cell protrusions. Considering that the
effect of cyclodextrin mediated cholesterol reduction is reversed
within a few hours, the longer-term effects of cholestenone may be
useful in instances where an acute cholesterol manipulation is
desired to produce prolonged cellular effects.
Materials and Methods
Cells and media
Primary HDFs (AG08498 from Coriell Cell Repositories) were
grown in DMEM (Lonza) supplemented with 10% non-heat
inactivated fetal bovine serum (FBS) (Gibco), 100 U/ml penicillin
and streptomycin, and 2 mM L-glutamine.
Coase and MBCD treatments
For cholesterol oxidation, cells were incubated in Dulbecco’s
phosphate buffered saline, calcium, magnesium (Gibco), 10 mM
Hepes (pH 7.3), glucose (1 g/l) (DPBS+) containing 10 U/ml
coase (Streptomyces sp., Calbiochem) for 1 h at 37uC. For
moderate cholesterol depletion, cells were subjected to 0.5 mM
MBCD (Sigma) for 5 min at 37uC, and for more extensive
cholesterol extraction, to 5 mM MBCD for 1 h at 37uC. For
cholesterol/cholestenone exchange, cells were treated with
0.5 mM MBCD-cholestenone complex (MBCD/cholestenone
6:1) for 15 min at 37uC.
Biochemical lipid analysis
Lipids were extracted according to Bligh and Dyer [35] and
separated on HP-TLC by using hexane/diethyl ether/acetic acid
(80:20:1) as the running solvent. Lipids were visualised by dipping
the TLC plate in 3% CuSO4, 8% H2PO4 and charring. Lipids
were identified based on standards, and the signal intensity was
quantified using ImageJ software. Cholestenone was the only
product detected in cells treated by coase (Figure S2A).
Radiolabeled lipids were scraped from the TLC plate according
to lipid standards directly into Optiphase ‘Hisafe’ 3 scintillation
cocktail (Perkin Elmer) and quantified by scintillation counting. No
radioactivity above background was detected outside the choles-
terol and cholestenone regions, except for a low signal corre-
sponding to cholesteryl esters, suggesting that [14C]cholesterol and
[14C]cholestenone are not catabolized in fibroblasts.
LD isolation
RAW 264.7 macrophages were grown in DMEM, 10% FBS,
10 mM Hepes (pH 7.3). Two 75 cm2 flasks of RAW 264.7
macrophages were loaded with 400 mM oleic acid –BSA complex
and labeled with 0.1 mM 4-[14C]cholesterol (specific activity,
53.0 mCi/mmol, Perkin Elmer) for 18 h in DMEM, 10% FBS,
10 mM Hepes (pH 7.3). Cells were washed twice with PBS and
treated with 10 U/ml coase for 2 h 37uC in DPBS+ or mock
treated in buffer only. Cells were collected in PBS, and lysed in
1.7 ml of hypotonic lysis buffer (HLB) [20 mM Tris–HCl, pH 7.4;
1 mM EDTA] including a protease inhibitor mixture (chymosta-
tin, leupeptin, antipain, and pepstatin A; 20 mg/ml each) on ice.
The lysate was centrifuged at 4uC, 10006g for 10 min to remove
the nuclei. Then, 1.3 ml of the supernatant was mixed with
0.65 ml of 60% sucrose solution to reach a final concentration of
20% sucrose. The samples were transferred to SW50 tubes, and
overlaid with 1.7 ml 5% sucrose in HLB and 1.3 ml HLB. The
samples were centrifuged for 2 h at 28 0006g, and the LD
fraction was recovered from the top of the gradient by using a tube
slicer; six additional fractions were collected and the fractions were
immediately used for lipid extraction.
were determined; n = 6–12. E) HDFs were treated with MB-CN complex as in D, wounded with a pipette tip and incubated in serum-free buffer for
22 h. Cells were stained with Alexa568-phalloidin and the wound area was imaged.
doi:10.1371/journal.pone.0103743.g005
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Preparation of BODIPY-lipid/MBCD complex
Bpy-cholestenone was prepared via a ruthenium-catalyzed
Oppenauer-type oxidation [36] of Bpy-cholesterol by the following
procedure. A solution of Bpy-cholesterol (3.3 mg, 5.7 mmol) in
2 ml of acetone was purged with nitrogen for 10 min. The
commercially available Shvo catalyst (2.0 mg, 1.8 mmol) was
quickly added, and the resulting solution was heated at reflux
(56uC) with stirring under nitrogen for 4 h. After the reaction
mixture was cooled to room temperature, the solvent was removed
under reduced pressure. The residue was purified by flash
chromatography (hexane/EtOAc 5:1 to 4:1) on silica gel to afford
1.3 mg (40% yield) of Bpy-cholestenone and 0.8 mg (24% yield) of
BODIPY-cholest-4-en-3,6-di-one, which were eluted in separate
fractions. Data for Bpy-cholestenone: 1H NMR (500 MHz,
Figure 6. Defective lamellipodial spreading of migrating coase treated cells. A) HDFs were treated, wounded and stained with phalloidin as
in Figure 5. B) The width of the lamellipodium was measured from control, MBCD and coase treated cells. Data represent 4 biological replicates per
condition; n = 172–228 cells. C) Cells were fixed at 3 h post wounding and stained with fluorescent phalloidin, and anti-Arp2/3 complex component
ARPC2 antibody, followed by secondary fluorescent antibody and imaging by confocal microscopy. Please note comparable image acquisition and
display in Arp2/3 panels; inset with increased brightness demonstrates the largely cytoplasmic staining pattern of Arp2/3 in coase treated cells. Scale
bars, 10 mm.
doi:10.1371/journal.pone.0103743.g006
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CDCl3) d 0.75 (s, 3H), 0.80–1.88 (m, 25H), 1.99–2.09 (m, 2H),
2.24–2.42 (m, 2H), 2.43 (s, 6H), 2.52 (s, 6H), 2.72 (dt, J=2.7,
12.8 Hz, 1H), 3.15 (dt, J=5.7, 12.8 Hz, 1H), 5.73 (s, 1H), 6.05 (s,
2H); ESI-HRMS (M+H2HF)+ calcd for C36H49BFN2O+
555.3923, found 555.3925. Data for BODIPY-cholest-4-en-3,6-
di-one: 1H NMR (500 MHz, CDCl3) d 0.75 (s, 3H), 0.80–1.80 (m,
19H), 1.84–1.95 (m, 3H), 1.99–2.07 (m, 1H), 2.11–2.18 (m, 2H),
2.43 (s, 6H), 2.47–2.49 (m, 1H), 2.52 (s, 6H), 2.67 (dd, J=4.0,
16.0 Hz, 1H), 2.73 (dt, J=3.1, 12.8 Hz, 1H), 3.16 (dt, J=5.6,
12.8 Hz, 1H), 6.05 (s, 2H), 6.17 (s, 1H); ESI-HRMS (M+H)+ calcd
for C36H48BF2N2O2
+ 589.3778, found 589.3774.
Bpy-cholesterol was synthesized as described [37]. 370 mM
MBCD solution was added to Bpy-cholesterol and Bpy-choleste-
none in a 100:1 molar ratio. The Bpy-lipids were solubilized by
bath sonication for 665 min at 37uC, and undissolved Bpy-lipids
were removed by centrifugation (15 min, 16 0006g). The
complexes were stored at 4uC and used within 2 weeks of
preparation.
Fluorescence imaging
Bpy-cholesterol and Bpy-cholestenone were incorporated into
HDFs by incubating the cells for 8 min with 0.18 mM MBCD
complexed with the lipid. Cells were washed twice with PBS and
immediately imaged with a Leica SP2 confocal microscope (Leica
Microsystems) with 636 (NA=0.90) water dipping objective, in
CO2 independent medium (Gibco) containing 10% FBS. Fluo-
rescent lipids were extracted and separated by HP-TLC using
hexane/ethyl acetate 4:1 running buffer and visualised by a FLA-
900 imager (GE Healthcare) with 488 nm wavelength. Based on
HP-TLC, no major catabolic products were generated from either
Bpy-cholesterol or Bpy-cholestenone (Figure S2B). For LD
detection, cells were co-labeled with 5 mM BODIPY558/568-
C12 (Life Technologies) and 1 mM Bpy-cholesterol or 1 mM Bpy-
cholestenone in DMEM containing 0.2% DMSO for 1 h. Cells
were imaged live after a 1 h chase. For immunofluorescence
microscopy, cells were fixed at room temperature with 4%
paraformaldehyde (PFA), and permeabilized with 0.1% Triton X-
100 for 5 min. Cells were stained in 10% FBS in PBS by
incubating with primary antibodies at 4uC overnight, then with
secondary antibodies for 45 min at 37uC, and finally mounted in
Mowiol containing 2.5% 1,4-diazabicyclo[2.2.2]octane. Confocal
images were acquired with a Leica TCS SP8 confocal microscope
(Leica Microsystems), with 406 (NA=1.1) water or 606
(NA=1.3) glycerol objectives. Anti-ARPC2 was purchased from
Upstate (p34Arc) (07-277).
Efflux assays
Bpy-lipids were incorporated into HDFs from a MBCD
complex as above. To analyse the efflux of Bpy-lipids, cells were
washed twice with PBS and immediately lysed in 1% NP-40, or
incubated for 4 h in DMEM, 10% FBS, washed twice, and lysed.
Bpy-fluorescence was measured using a Victor microplate reader
(Perkin Elmer). To analyse the efflux of radiolabeled lipids, HDFs
were labeled with 0.2 mCi/ml 4-[14C]cholesterol for 42 h in
DMEM, 10% FBS. Cells were washed with PBS to remove excess
label, and treated with coase and MBCD as described above. Cells
were then washed and incubated in DPBS+ containing 10 mg/ml
ApoA-I or 0.2% BSA for 4 h. Cells and media were collected and
lipids were extracted and analysed by HP-TLC.
Wound-healing assay
Confluent HDF monolayers were scratched with a pipette tip.
Cells were incubated in DPBS+, fixed at the indicated time points,
stained with Alexa568-phalloidin (Molecular probes) and imaged
with an AX70 epifluorescence microscope (Olympus) equipped
with an Olympus DP71 CCD camera using a 46 objective.
Images were analysed with ImageJ software by thresholding and
automatically measuring the wound area. The migration area was
calculated as the difference between the wound area at 0 h and
22 h post wounding.
Generalized polarization analysis
GP is described as: (I400–4602I470–530)/(I400–460+I470–530).
Cells were labeled with 5 mM Laurdan in serum-free DMEM
for 45 min at 37uC, washed, and fixed in 4% PFA. Mounted
coverslips were imaged with a Leica TCS SP8 confocal
microscope, with 636 (NA=1.3) glycerol objective, by two-
photon imaging. Laurdan was excited at 800 nm and emission was
recorded at 400–460 and 470–530 nm. The images were analysed
with ImageJ software by using a GP analysis macro provided in
[38] and corrected for G factor obtained from measuring Laurdan
emission in pure DMSO [38]. The resulting images were
generated as a merge of Laurdan fluorescence intensity in ordered
channel and GP value in the corresponding pixel. Data were
normalized to an average GP value of control samples from
different experiments.
Statistical analysis
Student’s t-test was used for statistical analysis. Data are
reported as mean +/2 standard error of mean (SEM).
Atomistic simulations and analysis of simulation data
We studied two raft-like lipid bilayers through unbiased MD
simulations (Table 3). One of them was composed of 256 POPC,
128 PSM, and 128 cholesterol (chol) molecules (POPC/PSM/
cholesterol/cholestenone; molar ratio of 2:1:1:0) (system IMD). In
the other, part of cholesterol molecules were replaced with
cholestenone, and this system contained 256 POPC, 128 PSM,
102 cholesterol, and 26 cholestenone (cnone) molecules (POPC/
PSM/cholesterol/cholestenone; molar ratio of 2:1:0.8:0.2) (system
IIMD). Both bilayers were hydrated with approximately 30000
water molecules. The initial membrane structures were obtained
from our previous study [39]. To parameterize the interactions in
the systems, for lipid molecules we used the all-atom optimized
potentials for liquid simulation (OPLS) force field [40], following
our previous works [41,42]. This set of charges was derived in
compliance with the OPLS methodology. For water, we employed
the TIP3P model, which is compatible with the OPLS parame-
terization [43].
Simulations were performed with GROMACS software [44],
using the GROMACS 4.6.5 package. All MD simulations were
200 ns long, and the first 20 ns were considered as an
equilibration period. Periodic boundary conditions with the usual
minimum image convention were used in all three directions. The
LINCS algorithm [45] was used to preserve hydrogen covalent
bond lengths. The time step was set to 2 fs for numerical
integration. Simulations were carried out under isothermal-
isobaric (310 K, 1 bar) conditions. The temperature and pressure
of the systems were controlled by the v-rescale thermostat and the
Parrinello-Rahman barostat [46,47] with time constants of 0.1 ps
and 1 ps, respectively. The temperatures of the solute and the
solvent were controlled independently. For pressure, we used a
semi-isotropic control. The Lennard-Jones interactions were cut
off at 1.0 nm, and for the electrostatic interactions we employed
the particle mesh Ewald method [44] with a real space cutoff of
1.0 nm, b-spline interpolation (order of 6), and direct sum
tolerance of 1026.
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In free energy (FE) calculations with the umbrella sampling
technique [19] we used the same protocol as in unbiased MD
simulations. However, because of a large computational cost of FE
calculations, the system size was reduced to one-fourth of that used
in Table 3. The bilayers studied for FE computations were: (i)
system IFE – composed of 64 POPC, 32 PSM, and 32 cholesterol
molecules (POPC:PSM:cholesterol:cholestenone 2:1:1:0), (ii) sys-
tem IIFE – composed of 64 POPC, 32 PSM, 24 cholesterol, and 8
cholestenone lipids (POPC:PSM:cholesterol:cholestenone; molar
ratio of 2:1:0.75:0.25), and (iii) system IIIFE – in this bilayer
cholesterol was completely replaced by cholestenone and it
contained 64 POPC, 32 PSM, and 32 cholestenone molecules
(POPC:PSM:cholesterol:cholestenone; molar ratio of 2:1:0:1). In
addition to liquid-ordered (Lo) membranes, we also simulated two
liquid-disordered (Ld) bilayers containing 127 POPC molecules
with either one cholesterol (system IVFE) or one cholestenone
(system VFE) present in one of the two leaflets.
Before the FE calculations commenced, all bilayers were
simulated for 100 ns, of which the first 20 ns was considered as
equilibration and the rest of these data were used for analysis. We
then calculated the free energies of translocation (flip-flop) of
steroid molecules from their equilibrium position to the bilayer
center and further to the other leaflet, as well as the FE of steroid
desorption from a bilayer to the water phase. In these calculations,
we restrained the hydroxyl group of cholesterol and the ketone
oxygen of cholestenone together with three adjacent ring carbon
atoms for each steroid with respect to the center of mass of the
membrane, applying a harmonic restraint with a force constant of
750 kJ mol21 nm22. In each adjacent window, cholesterol/
cholestenone was moved by 0.1 nm in the direction normal to
the bilayer, with a total of 41 simulations to sample the entire
reaction coordinate. The windows were run for 50–100 ns. The
potential of mean force was calculated by the weighted histogram
analysis method (WHAM) [48], using the g_wham tool imple-
mented in GROMACS. The statistical errors were estimated with
bootstrap analysis [48].
The conformational ordering of lipid acyl chains was charac-
terized by the order parameter SCD=K,3 cos
2h21., where h is
the angle between the C–H bond vector and the membrane
normal. The angular brackets indicate averaging over time and
lipids. The largest value of 0.5 corresponds to full conformation
order (all-trans), while values close to zero describe a situation with
no conformational order (disordered acyl chains). The overall
shape of our order parameter profile, including the dip at smaller
carbon numbers, is in qualitative agreement with the previous
NMR-derived order parameter profile for POPC lipid [49].
The presence of hydrogen bonds was evaluated based on
distance and angle criteria: the donor- acceptor distance had to be
less than or equal to 0.325 nm, and the angle between the vector
linking a donor and an acceptor, and the vector describing the
chemical bond between hydrogen and a donor had to be less than
or equal to 35u. The existence of charge pairs was determined
using the distance cut-off of 0.4 nm. The geometric criterion used
in hydrogen bond and charge-pair estimation was derived from
our previous work [50].
The rates of cholesterol and cholestenone flip-flop were
calculated using the equation kf= kd6exp (2DGcenter/RT), where
DGcenter is the difference in free energy between the bilayer center
(Zcenter) and the equilibrium position Zeq that is the position of the
free energy minimum. Then kf is the rate constant to move from
Zeq to Zcenter, and kd is the rate constant with which a molecule
returns from Zcenter to Zeq in terms of kd=1/td. Here the time td is
the estimated time-range for steroid molecules to move from
Zcenter to Zeq. This can be estimated by releasing the harmonic
restraint on a steroid at Zcenter, and then computing the time that it
takes to return back to Zeq. Instead of attempting a more rigorous
estimation, a time range of 1–80 ns was used for cholesterol
(considering the previous report on cholesterol flip-flop in different
bilayer membranes, including raft-mimicking environments [20]).
The same value was used for cholesterol in all bilayers. For
cholestenone, a time range of 1–40 ns was used for all bilayers (the
time range was based on present findings and an earlier report by
Ro´g et al. [51]). Since a complete flip-flop event involves the rate
to move from bilayer equilibrium to the center (kf) and then from
the center to the opposite leaflet (kd), the rate constant of flip-flop is
expressed as kflip=K61/[kf
21+kd21]<kf/2.
Supporting Information
Figure S1 The mean-squared displacement (MSD) of
palmitoyl-sphingomyelin (PSM) in the membrane plane.
The lipid compositions of the studied systems differed with respect
to cholesterol/cholestenone as indicated. The black line represents
the lateral displacement of PSM in the raft-like bilayer containing
25% cholesterol, while the red line represents the corresponding
MSD data when all membrane cholesterol was replaced by
cholestenone. In the calculation of the MSD, the first 20 ns were
removed from the simulation trajectory. Mean-squared displace-
ment (MSD) of single-lipid motion for PSM was calculated:
Table 3. Lipid compositions for all the bilayersa used in the present work.
System POPC PSM Cholesterol Cholestenone Phase Area per lipidb (A˚2)
IMD 256 128 128 0 Lo 59.3160.57
IIMD 256 128 102 26 Lo 59.2060.53
IFE 64 32 32 0 Lo 59.0160.91
IIFE 64 32 24 8 Lo 58.9661.01
IIIFE 64 32 0 32 Lo 57.9561.37
IVFE 127 0 1 0 Ld 68.7561.23
VFE 127 0 0 1 Ld 68.1161.33
aThe subscripts ‘‘MD’’ refer to the systems studied only by regular (unbiased) molecular dynamics simulations, thus they were not used in free energy calculations. The
subscripts ‘‘FE’’ refer to the systems used for free energy calculations. Lo and Ld stand for liquid-ordered and liquid-disordered phases, respectively.
bArea per lipid calculated by dividing the time averaged total area of each simulation system by the number of lipids per leaflet.
The numbers of each lipid in a given system, the phase, and the area per lipid are indicated.
doi:10.1371/journal.pone.0103743.t003
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MSD(t) =,|ri (t+t)2ri (t)|2.i,t], where ri(t) is the position of lipid
i at time t, and , .i,t stands for averaging over the lipids
i=1,2,…,N and the times t. Then the lateral diffusion coefficient
for the given lipid type is DL= limtR‘[1/(4t),|ri (t+t)2ri
(t)|2.i,t]. The center of mass motion of individual leaflets was
removed before calculation as monolayers can drift during the
simulation.
(TIF)
Figure S2 Chromatographic analysis of cholesterol,
cholestenone and their fluorescent analogs extracted
from HDFs. A. HDFs were treated with coase (10 U/ml; 1 h at
37uC). Cells were collected after 22 h chase and the lipids were
extracted and analysed by HP-TLC. Standards: CHOL= choles-
terol, CNONE= cholestenone, TG= triglycerides, CE= choles-
teryl esters. B. HDFs were pulse labeled for 30 min with 1 mM
Bpy-cholesterol (Bpy-chol) or Bpy-cholestenone (Bpy-cnone). Cells
were collected immediately after labeling (0 h) or after 4 h chase,
and the lipids were extracted and analysed by HP-TLC.
(TIF)
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